|Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization|
N Nakamoto, DE Kaplan, J Coleclough, Y Li, ME Valiga, M Kaminski, ...
Gastroenterology 134 (7), 1927-1937. e2, 2008
|Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C|
DE Kaplan, K Sugimoto, K Newton, ME Valiga, F Ikeda, A Aytaman, ...
Gastroenterology 132 (2), 654-666, 2007
|Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores|
GN Ioannou, LA Beste, PK Green, AG Singal, EB Tapper, AK Waljee, ...
Gastroenterology 157 (5), 1264-1278. e4, 2019
|Reciprocal actions of interleukin‐6 and brain‐derived neurotrophic factor on rat and mouse primary sensory neurons|
PG Murphy, LA Borthwick, M Altares, J Gauldie, D Kaplan, PM Richardson
European Journal of Neuroscience 12 (6), 1891-1899, 2000
|Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality|
M Serper, TH Taddei, R Mehta, K D’Addeo, F Dai, A Aytaman, ...
Gastroenterology 152 (8), 1954-1964, 2017
|Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans|
DS Goldberg, B French, KA Forde, PW Groeneveld, T Bittermann, ...
Jama 311 (12), 1234-1243, 2014
|Dysfunctional B‐cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27‐Positive B‐cell population|
H Doi, TK Iyer, E Carpenter, H Li, KM Chang, RH Vonderheide, ...
Hepatology 55 (3), 709-719, 2012
|Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis|
DE Kaplan, F Ikeda, Y Li, N Nakamoto, S Ganesan, ME Valiga, FA Nunes, ...
Journal of hepatology 48 (6), 903-913, 2008
|Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study|
V Lo Re III, V Teal, AR Localio, VK Amorosa, DE Kaplan, R Gross
Annals of internal medicine 155 (6), 353-360, 2011
|Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes|
T Kushner, M Serper, DE Kaplan
Journal of hepatology 63 (3), 586-592, 2015
|Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular‐cholangiocarcinoma|
X Cai, J Zhai, DE Kaplan, Y Zhang, L Zhou, X Chen, G Qian, Q Zhao, Y Li, ...
Hepatology 56 (5), 1804-1816, 2012
|Incidence and mortality of acute‐on‐chronic liver failure using two definitions in patients with compensated cirrhosis|
N Mahmud, DE Kaplan, TH Taddei, DS Goldberg
Hepatology 69 (5), 2150-2163, 2019
|Development and performance of an algorithm to estimate the Child-Turcotte-Pugh score from a national electronic healthcare database|
DE Kaplan, F Dai, A Aytaman, M Baytarian, R Fox, K Hunt, A Knott, ...
Clinical Gastroenterology and Hepatology 13 (13), 2333-2341. e6, 2015
|Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis|
DS Goldberg, TH Taddei, M Serper, R Mehta, E Dieperink, A Aytaman, ...
Hepatology 65 (3), 864-874, 2017
|Relative performance of commercial banks in India using CAMEL approach|
International Journal of Multidisciplinary Research 2 (3), 38-58, 2012
|Focal distribution of hepatitis C virus RNA in infected livers|
JD Stiffler, M Nguyen, JA Sohn, C Liu, D Kaplan, C Seeger
PLoS One 4 (8), e6661, 2009
|Starting dose of sorafenib for the treatment of hepatocellular carcinoma: a retrospective, multi-institutional study|
KA Reiss, S Yu, R Mamtani, R Mehta, K D’Addeo, EP Wileyto, TH Taddei, ...
Journal of Clinical Oncology 35 (31), 3575, 2017
|Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans|
RA Harris, K Sugimoto, DE Kaplan, F Ikeda, M Kamoun, KM Chang
Hepatology 48 (1), 70-79, 2008
|T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C|
DE Kaplan, K Sugimoto, F Ikeda, J Stadanlick, M Valiga, K Shetty, ...
Hepatology 41 (6), 1365-1375, 2005
|Rare birds in North America: acute hepatitis C cohorts|
AL Cox, K Page, J Bruneau, NH Shoukry, GM Lauer, AY Kim, HR Rosen, ...
Gastroenterology 136 (1), 26-31, 2009